Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.71 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.54 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30232040 | 0.95 | OPRM1 (0.65) | OPRM1OPRD1SLC6A2NTSR2NTSR1 | |
| SCHEMBL29569996 | 0.93 | OPRM1 (0.75) | OPRM1OPRD1SLC6A2F2NTSR2 | |
| SCHEMBL31679387 | 0.93 | OPRM1 (0.66) | OPRM1OPRD1SLC6A2F2 | |
| SCHEMBL30273400 | 0.92 | OPRM1 (0.64) | OPRM1OPRD1SLC6A2F2NTSR2 | |
| SCHEMBL31370870 | 0.91 | OPRM1 (0.63) | OPRM1OPRD1SLC6A2NTSR2NTSR1 | |
| SCHEMBL31167614 | 0.91 | OPRM1 (0.75) | OPRM1OPRD1SLC6A2F2NTSR2 | |
| SCHEMBL29630770 | 0.91 | SLC6A2 (0.67) | OPRM1OPRD1SLC6A2 | |
| SCHEMBL29569657 | 0.90 | OPRM1 (0.64) | OPRM1OPRD1SLC6A2F2NTSR2 | |
| SCHEMBL31509501 | 0.90 | NTSR1 (0.61) | OPRM1OPRD1SLC6A2NTSR2NTSR1 | |
| SCHEMBL31411493 | 0.89 | NTSR1 (0.62) | OPRM1OPRD1SLC6A2NTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |